$RNA
Atrium Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
RNA chart
What traders are saying about $RNA
Latest postsAtrium Therapeutics, Inc. news
- Atrium Therapeutics Doses First Patient in Phase 1/2 Trial of ATR 1072
marketscreener.com ·
- Form 8K Atrium Therapeutics Inc For: 27 October By Investing.com
Investing.com Canada ·
- Form 8-K Atrium Therapeutics, For: Oct 27
StreetInsider ·
- Atrium Therapeutics doses first patient in PRKAG2 syndrome trial
StreetInsider ·
- Atrium Therapeutics starts Phase 1/2 trial for ATR 1072 targeting rare PRKAG2 heart syndrome.
Pluang ·
- Atrium Therapeutics Doses First Patient in Corventis™, the First Interventional Clinical Trial for People Living with PRKAG2 Syndrome
Yahoo Finance ·
- A rare heart condition’s first trial tests a treatment aimed at its genetic cause
Stock Titan ·
- Atrium Therapeutics, Inc. Estimates – NASDAQ:RNA
TradingView ·
- Atrium Therapeutics is a buy, this analyst says
Cantech Letter ·
- Roth/MKM initiates Atrium Therapeutics stock with buy rating
Investing.com ·
- Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Yakira Capital Management Calls on Atrium Therapeutics to Launch Strategic Review, Curb Cash Spending and Explain Dilutive Financing
Yahoo Finance ·
Atrium Therapeutics, Inc. key financials
| USD | 2025 |
|---|---|
| Total assets (year end) | $8.4M |
| Cash and equivalents (year end) | $0 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Atrium Therapeutics, Inc.
- Ticker
- RNA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2093101
Frequently asked questions
What exchange is Atrium Therapeutics, Inc. listed on?
Atrium Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RNA.
What industry is Atrium Therapeutics, Inc. in?
Atrium Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Atrium Therapeutics, Inc. headquartered?
Atrium Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Atrium Therapeutics, Inc.'s fiscal year end?
Atrium Therapeutics, Inc.'s fiscal year ends on December 31.